Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux® (cetuximab) product information, updating the indication for Erbitux to the ...
Merck Serono has signed a license agreement with the Spanish National Cancer Research Centre (CNIO) in Madrid in the area of cancer drug development and will build upon CNIO research discoveries to support the development and ...
Tags: Cancer Patients, Merck Serono
c Gonal-f RFF Redi-ject is a disposable pre-filled drug injector pen intended for the subcutaneous injection of a liquid formulation of Gonal-f RFF (revised formulation female). The fertility pen has been redesigned to incorporate the ...
Tags: Fertility Pen, EMD Serono
The Bill & Melinda Gates Foundation has granted $1.15m funding to a global public-private partnership (PPP), to develop a new pediatric formulation to fight schistosomiasis, commonly known as bilharzia, in preschool children. Formed in ...
Tags: Schistosomiasis Drug, Medicine
Finnish diabetes technology company Mendor has entered into partnership with Europe-based diagnostics company A. Menarini Diagnostics for distribution of its blood glucose monitoring system. Under the terms of the agreement, Mendor's ...
Tags: A.Menarini Diagnostics, Blood Glucose Monitoring System
Aeterna Zentaris has transferred manufacturing license for its Cetrotide (cetrorelix acetate for injection) product to German-based Merck Serono. Cetrotide is used in women undergoing infertility treatment for the regulation of hormone ...
Tags: Aeterna, Merck Serono, Medicine
Canbex Therapeutics has completed a 2.1m ($3.2m) fundraising round to complete early development of drug candidate to treat spasticity in multiple sclerosis (MS). The financing for the round was led by Merck Serono Ventures, the venture ...
Tags: Canbex Therapeutics, Canbex
Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs
Corpak MedSystems has entered into a definitive agreement to purchase gastroenterology sales and distribution operation of Merck Serono in the UK and Ireland. Merck Serono commercial director Charles Dring said the gastroenterology ...
Merck Serono has entered into a collaboration agreement to provide strategic, scientific and medical support in the development and commercialization of Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) test. The Eeva test, ...
Tags: Eeva test, non-invasive computerized test, embryo selection
Merck Serono, a division of Merck, and Auxogyn have partnered to develop Early Embryo Viability Assessment (Eeva) test. Pursuant to the deal, Merck Serono will provide strategic, scientific and medical support for the development of ...
Tags: Early Embryo Viability Assessment test, eeva test, clinical development
TI Pharma, Merck KGaA, Astellas Pharma and the Swiss Tropical and Public Health Institute (Swiss TPH) have entered into an international public-private partnership (PPP) to develop new pediatric formulation of praziquantel for the treatment ...
Tags: Pediatric Formulation, Swiss TPH, treatment of schistosomiasis
Merck Serono, a division of Merck, Darmstadt, Germany, and Compugen have announced the establishment of a new biomarker company, Neviah Genomics. Neviah Genomics, which is the first company to be funded within the framework of Merck ...
Tags: Compugen, Merck Serono, genomics
Newron Pharmaceuticals has signed a strategic collaboration and licence agreement with Zambon Company for Safinamide in the EU and US. As per the agreement, Zambon will initially invest €20m into Newron, covering the completion ...
Tags: collaboration, pharmaceutical product, clinical development, Safinamide